HCPCS Level IIdrugActive
J0175
Inj, donanemab-azbt, 2 mg
BETOS: O1E
Effective: 2024-07-02
Description
Injection, donanemab-azbt, 2 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Kisunla
Manufacturer
Eli Lilly and Company
HCPCS Dosage
2 MG
Billing Units
175.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.